About MedAvante-ProPhase
MedAvante-ProPhase is a company based in Hamilton (United States) founded in 2002 by Paul Gilbert was acquired by WIRB-Copernicus Group in May 2017.. MedAvante-ProPhase has raised $2.29 million across 1 funding round from investors including WIRB-Copernicus Group and Arsenal Capital Partners. MedAvante-ProPhase offers products and services including IRB Review, Site Enablement, and Clinical Endpoints. MedAvante-ProPhase operates in a competitive market with competitors including Suvoda, Circuit Clinical, HumanFirst, Curavit and Raylytic, among others.
- Headquarter Hamilton, United States
- Founders Paul Gilbert
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$2.29 M (USD)
in 1 rounds
-
Latest Funding Round
$2.29 M (USD), Series A
Oct 08, 2015
-
Investors
WIRB-Copernicus Group
& 1 more
-
Employee Count
Employee Count
-
Acquired by
WIRB-Copernicus Group
(May 09, 2017)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of MedAvante-ProPhase
MedAvante-ProPhase offers a comprehensive portfolio of products and services, including IRB Review, Site Enablement, and Clinical Endpoints. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Service for ethical and scientific review of clinical trials
Platform for site preparation and operational support
Tools for monitoring and assessing trial outcomes
Unlock access to complete
Unlock access to complete
Software Development Team
65 people
Operations Team
56 people
Leadership Team
46 people
Senior Team
36 people
Sales and Marketing
28 people
Project Team
19 people
Legal and Compliance
14 people
Finance and Accounting
14 people
Unlock access to complete
Funding Insights of MedAvante-ProPhase
MedAvante-ProPhase has successfully raised a total of $2.29M through 1 strategic funding round. The most recent funding activity was a Series A round of $2.29 million completed in October 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series A — $2.3M
-
First Round
First Round
(08 Oct 2015)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2015 | Amount | Series A - MedAvante-ProPhase | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in MedAvante-ProPhase
MedAvante-ProPhase has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include WIRB-Copernicus Group and Arsenal Capital Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity investments target specialty industrials and healthcare sectors.
|
Founded Year | Domain | Location | |
|
Regulatory and ethical review services for clinical research are provided.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by MedAvante-ProPhase
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - MedAvante-ProPhase
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Medavante-Prophase Comparisons
Competitors of MedAvante-ProPhase
MedAvante-ProPhase operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Suvoda, Circuit Clinical, HumanFirst, Curavit and Raylytic, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Clinical trial management solutions are provided through Suvoda's IRT system.
|
|
| domain | founded_year | HQ Location |
Research site network platform focuses on patient identification, enrollment, recruitment & retention
|
|
| domain | founded_year | HQ Location |
HumanFirst is integrated into ICON, focusing on digital health solutions.
|
|
| domain | founded_year | HQ Location |
Contract research organization that offers a complete suite of CRO services for decentralized clinical trials
|
|
| domain | founded_year | HQ Location |
Solutions for medical image analysis, data management, workflow automation & EPR collection
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about MedAvante-ProPhase
When was MedAvante-ProPhase founded?
MedAvante-ProPhase was founded in 2002 and raised its 1st funding round 13 years after it was founded.
Where is MedAvante-ProPhase located?
MedAvante-ProPhase is headquartered in Hamilton, United States.
Is MedAvante-ProPhase a funded company?
MedAvante-ProPhase is a funded company, having raised a total of $2.29M across 1 funding round to date. The company's 1st funding round was a Series A of $2.29M, raised on Oct 08, 2015.
What does MedAvante-ProPhase do?
MedAvante-ProPhase was founded in 2002 and is based in Hamilton, United States. Operations focus on the healthcare technology sector, where eSource data capture and electronic data management systems are offered for clinical trials. The flagship Virgil Investigative Study Platform is utilized for signal detection, incorporating tablet-based interfaces with context-sensitive rating scales and clinical guidance tailored to specific studies. Services support data integrity and efficiency in trial processes.
Who are the top competitors of MedAvante-ProPhase?
MedAvante-ProPhase's top competitors include Suvoda, HumanFirst and Circuit Clinical.
What products or services does MedAvante-ProPhase offer?
MedAvante-ProPhase offers IRB Review, Site Enablement, and Clinical Endpoints.
Who are MedAvante-ProPhase's investors?
MedAvante-ProPhase has 2 investors. Key investors include WIRB-Copernicus Group, and Arsenal Capital Partners.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.